Global Infectious Disease In-vitro Diagnostic Market Size, Status and Forecast 2021-2027
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunoassay
1.2.3 Molecular Diagnostics
1.2.4 Microbiology
1.2.5 Others
1.3 Market by Application
1.3.1 Global Infectious Disease In-vitro Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 COVID-19
1.3.3 MRSA
1.3.4 Clostridium Difficile
1.3.5 Respiratory Virus
1.3.6 TB and Drug-resistant TB
1.3.7 Chlamydia
1.3.8 Gonorrhea
1.3.9 HPV
1.3.10 HIV
1.3.11 Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease In-vitro Diagnostic Market Perspective (2016-2027)
2.2 Infectious Disease In-vitro Diagnostic Growth Trends by Regions
2.2.1 Infectious Disease In-vitro Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infectious Disease In-vitro Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Infectious Disease In-vitro Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Infectious Disease In-vitro Diagnostic Industry Dynamic
2.3.1 Infectious Disease In-vitro Diagnostic Market Trends
2.3.2 Infectious Disease In-vitro Diagnostic Market Drivers
2.3.3 Infectious Disease In-vitro Diagnostic Market Challenges
2.3.4 Infectious Disease In-vitro Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease In-vitro Diagnostic Players by Revenue
3.1.1 Global Top Infectious Disease In-vitro Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Infectious Disease In-vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease In-vitro Diagnostic Revenue
3.4 Global Infectious Disease In-vitro Diagnostic Market Concentration Ratio
3.4.1 Global Infectious Disease In-vitro Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease In-vitro Diagnostic Revenue in 2020
3.5 Infectious Disease In-vitro Diagnostic Key Players Head office and Area Served
3.6 Key Players Infectious Disease In-vitro Diagnostic Product Solution and Service
3.7 Date of Enter into Infectious Disease In-vitro Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease In-vitro Diagnostic Breakdown Data by Type
4.1 Global Infectious Disease In-vitro Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Type (2022-2027)
5 Infectious Disease In-vitro Diagnostic Breakdown Data by Application
5.1 Global Infectious Disease In-vitro Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Infectious Disease In-vitro Diagnostic Market Size (2016-2027)
6.2 North America Infectious Disease In-vitro Diagnostic Market Size by Type
6.2.1 North America Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Infectious Disease In-vitro Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2027)
6.3 North America Infectious Disease In-vitro Diagnostic Market Size by Application
6.3.1 North America Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Infectious Disease In-vitro Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2027)
6.4 North America Infectious Disease In-vitro Diagnostic Market Size by Country
6.4.1 North America Infectious Disease In-vitro Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Infectious Disease In-vitro Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Infectious Disease In-vitro Diagnostic Market Size (2016-2027)
7.2 Europe Infectious Disease In-vitro Diagnostic Market Size by Type
7.2.1 Europe Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Infectious Disease In-vitro Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2027)
7.3 Europe Infectious Disease In-vitro Diagnostic Market Size by Application
7.3.1 Europe Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Infectious Disease In-vitro Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2027)
7.4 Europe Infectious Disease In-vitro Diagnostic Market Size by Country
7.4.1 Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Type
8.2.1 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Application
8.3.1 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region
8.4.1 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Infectious Disease In-vitro Diagnostic Market Size (2016-2027)
9.2 Latin America Infectious Disease In-vitro Diagnostic Market Size by Type
9.2.1 Latin America Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Infectious Disease In-vitro Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Infectious Disease In-vitro Diagnostic Market Size by Application
9.3.1 Latin America Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Infectious Disease In-vitro Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Infectious Disease In-vitro Diagnostic Market Size by Country
9.4.1 Latin America Infectious Disease In-vitro Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Infectious Disease In-vitro Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Type
10.2.1 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Application
10.3.1 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country
10.4.1 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Infectious Disease In-vitro Diagnostic Introduction
11.1.4 BD Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021)
11.1.5 BD Recent Development
11.2 BioMérieux SA
11.2.1 BioMérieux SA Company Details
11.2.2 BioMérieux SA Business Overview
11.2.3 BioMérieux SA Infectious Disease In-vitro Diagnostic Introduction
11.2.4 BioMérieux SA Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021)
11.2.5 BioMérieux SA Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Infectious Disease In-vitro Diagnostic Introduction
11.3.4 Abbott Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 Quidel Corporation
11.4.1 Quidel Corporation Company Details
11.4.2 Quidel Corporation Business Overview
11.4.3 Quidel Corporation Infectious Disease In-vitro Diagnostic Introduction
11.4.4 Quidel Corporation Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021)
11.4.5 Quidel Corporation Recent Development
11.5 OraSure Technologies, Inc.
11.5.1 OraSure Technologies, Inc. Company Details
11.5.2 OraSure Technologies, Inc. Business Overview
11.5.3 OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Introduction
11.5.4 OraSure Technologies, Inc. Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021)
11.5.5 OraSure Technologies, Inc. Recent Development
11.6 Hologic, Inc. (Gen Probe)
11.6.1 Hologic, Inc. (Gen Probe) Company Details
11.6.2 Hologic, Inc. (Gen Probe) Business Overview
11.6.3 Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Introduction
11.6.4 Hologic, Inc. (Gen Probe) Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021)
11.6.5 Hologic, Inc. (Gen Probe) Recent Development
11.7 Danaher
11.7.1 Danaher Company Details
11.7.2 Danaher Business Overview
11.7.3 Danaher Infectious Disease In-vitro Diagnostic Introduction
11.7.4 Danaher Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021)
11.7.5 Danaher Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Details
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Infectious Disease In-vitro Diagnostic Introduction
11.8.4 QIAGEN Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021)
11.8.5 QIAGEN Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche Infectious Disease In-vitro Diagnostic Introduction
11.9.4 Roche Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021)
11.9.5 Roche Recent Development
11.10 Siemens Healthineers AG
11.10.1 Siemens Healthineers AG Company Details
11.10.2 Siemens Healthineers AG Business Overview
11.10.3 Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Introduction
11.10.4 Siemens Healthineers AG Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021)
11.10.5 Siemens Healthineers AG Recent Development
11.11 Bio-Rad Laboratories, Inc.
11.11.1 Bio-Rad Laboratories, Inc. Company Details
11.11.2 Bio-Rad Laboratories, Inc. Business Overview
11.11.3 Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Introduction
11.11.4 Bio-Rad Laboratories, Inc. Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021)
11.11.5 Bio-Rad Laboratories, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Infectious Disease In-vitro Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunoassay
Table 3. Key Players of Molecular Diagnostics
Table 4. Key Players of Microbiology
Table 5. Key Players of Others
Table 6. Global Infectious Disease In-vitro Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Infectious Disease In-vitro Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Infectious Disease In-vitro Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Infectious Disease In-vitro Diagnostic Market Share by Regions (2016-2021)
Table 10. Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Infectious Disease In-vitro Diagnostic Market Share by Regions (2022-2027)
Table 12. Infectious Disease In-vitro Diagnostic Market Trends
Table 13. Infectious Disease In-vitro Diagnostic Market Drivers
Table 14. Infectious Disease In-vitro Diagnostic Market Challenges
Table 15. Infectious Disease In-vitro Diagnostic Market Restraints
Table 16. Global Infectious Disease In-vitro Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Infectious Disease In-vitro Diagnostic Market Share by Players (2016-2021)
Table 18. Global Top Infectious Disease In-vitro Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease In-vitro Diagnostic as of 2020)
Table 19. Ranking of Global Top Infectious Disease In-vitro Diagnostic Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Infectious Disease In-vitro Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Infectious Disease In-vitro Diagnostic Product Solution and Service
Table 23. Date of Enter into Infectious Disease In-vitro Diagnostic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Type (2016-2021)
Table 27. Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Infectious Disease In-vitro Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Application (2016-2021)
Table 31. Global Infectious Disease In-vitro Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Infectious Disease In-vitro Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Infectious Disease In-vitro Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Infectious Disease In-vitro Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Infectious Disease In-vitro Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Infectious Disease In-vitro Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Infectious Disease In-vitro Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Infectious Disease In-vitro Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Infectious Disease In-vitro Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Infectious Disease In-vitro Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Infectious Disease In-vitro Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Infectious Disease In-vitro Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 63. BD Company Details
Table 64. BD Business Overview
Table 65. BD Infectious Disease In-vitro Diagnostic Product
Table 66. BD Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021) & (US$ Million)
Table 67. BD Recent Development
Table 68. BioMérieux SA Company Details
Table 69. BioMérieux SA Business Overview
Table 70. BioMérieux SA Infectious Disease In-vitro Diagnostic Product
Table 71. BioMérieux SA Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021) & (US$ Million)
Table 72. BioMérieux SA Recent Development
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott Infectious Disease In-vitro Diagnostic Product
Table 76. Abbott Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. Quidel Corporation Company Details
Table 79. Quidel Corporation Business Overview
Table 80. Quidel Corporation Infectious Disease In-vitro Diagnostic Product
Table 81. Quidel Corporation Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021) & (US$ Million)
Table 82. Quidel Corporation Recent Development
Table 83. OraSure Technologies, Inc. Company Details
Table 84. OraSure Technologies, Inc. Business Overview
Table 85. OraSure Technologies, Inc. Infectious Disease In-vitro Diagnostic Product
Table 86. OraSure Technologies, Inc. Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021) & (US$ Million)
Table 87. OraSure Technologies, Inc. Recent Development
Table 88. Hologic, Inc. (Gen Probe) Company Details
Table 89. Hologic, Inc. (Gen Probe) Business Overview
Table 90. Hologic, Inc. (Gen Probe) Infectious Disease In-vitro Diagnostic Product
Table 91. Hologic, Inc. (Gen Probe) Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021) & (US$ Million)
Table 92. Hologic, Inc. (Gen Probe) Recent Development
Table 93. Danaher Company Details
Table 94. Danaher Business Overview
Table 95. Danaher Infectious Disease In-vitro Diagnostic Product
Table 96. Danaher Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021) & (US$ Million)
Table 97. Danaher Recent Development
Table 98. QIAGEN Company Details
Table 99. QIAGEN Business Overview
Table 100. QIAGEN Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021) & (US$ Million)
Table 101. QIAGEN Recent Development
Table 102. Roche Company Details
Table 103. Roche Business Overview
Table 104. Roche Infectious Disease In-vitro Diagnostic Product
Table 105. Roche Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021) & (US$ Million)
Table 106. Roche Recent Development
Table 107. Siemens Healthineers AG Company Details
Table 108. Siemens Healthineers AG Business Overview
Table 109. Siemens Healthineers AG Infectious Disease In-vitro Diagnostic Product
Table 110. Siemens Healthineers AG Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021) & (US$ Million)
Table 111. Siemens Healthineers AG Recent Development
Table 112. Bio-Rad Laboratories, Inc. Company Details
Table 113. Bio-Rad Laboratories, Inc. Business Overview
Table 114. Bio-Rad Laboratories, Inc. Infectious Disease In-vitro Diagnostic Product
Table 115. Bio-Rad Laboratories, Inc. Revenue in Infectious Disease In-vitro Diagnostic Business (2016-2021) & (US$ Million)
Table 116. Bio-Rad Laboratories, Inc. Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Infectious Disease In-vitro Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Immunoassay Features
Figure 3. Molecular Diagnostics Features
Figure 4. Microbiology Features
Figure 5. Others Features
Figure 6. Global Infectious Disease In-vitro Diagnostic Market Share by Application: 2020 VS 2027
Figure 7. COVID-19 Case Studies
Figure 8. MRSA Case Studies
Figure 9. Clostridium Difficile Case Studies
Figure 10. Respiratory Virus Case Studies
Figure 11. TB and Drug-resistant TB Case Studies
Figure 12. Chlamydia Case Studies
Figure 13. Gonorrhea Case Studies
Figure 14. HPV Case Studies
Figure 15. HIV Case Studies
Figure 16. Others(Gastro-intestinal Panel Testing, Hepatitis C, Hepatitis B, etc) Case Studies
Figure 17. Infectious Disease In-vitro Diagnostic Report Years Considered
Figure 18. Global Infectious Disease In-vitro Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Infectious Disease In-vitro Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Infectious Disease In-vitro Diagnostic Market Share by Regions: 2020 VS 2027
Figure 21. Global Infectious Disease In-vitro Diagnostic Market Share by Regions (2022-2027)
Figure 22. Global Infectious Disease In-vitro Diagnostic Market Share by Players in 2020
Figure 23. Global Top Infectious Disease In-vitro Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease In-vitro Diagnostic as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Infectious Disease In-vitro Diagnostic Revenue in 2020
Figure 25. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Type (2016-2021)
Figure 26. Global Infectious Disease In-vitro Diagnostic Revenue Market Share by Type (2022-2027)
Figure 27. North America Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Infectious Disease In-vitro Diagnostic Market Share by Type (2016-2027)
Figure 29. North America Infectious Disease In-vitro Diagnostic Market Share by Application (2016-2027)
Figure 30. North America Infectious Disease In-vitro Diagnostic Market Share by Country (2016-2027)
Figure 31. United States Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Infectious Disease In-vitro Diagnostic Market Share by Type (2016-2027)
Figure 35. Europe Infectious Disease In-vitro Diagnostic Market Share by Application (2016-2027)
Figure 36. Europe Infectious Disease In-vitro Diagnostic Market Share by Country (2016-2027)
Figure 37. Germany Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Infectious Disease In-vitro Diagnostic Market Share by Region (2016-2027)
Figure 47. China Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Infectious Disease In-vitro Diagnostic Market Share by Type (2016-2027)
Figure 55. Latin America Infectious Disease In-vitro Diagnostic Market Share by Application (2016-2027)
Figure 56. Latin America Infectious Disease In-vitro Diagnostic Market Share by Country (2016-2027)
Figure 57. Mexico Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Infectious Disease In-vitro Diagnostic Market Share by Country (2016-2027)
Figure 63. Turkey Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Infectious Disease In-vitro Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. BD Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2016-2021)
Figure 67. BioMérieux SA Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2016-2021)
Figure 68. Abbott Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2016-2021)
Figure 69. Quidel Corporation Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2016-2021)
Figure 70. OraSure Technologies, Inc. Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2016-2021)
Figure 71. Hologic, Inc. (Gen Probe) Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2016-2021)
Figure 72. Danaher Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2016-2021)
Figure 73. QIAGEN Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2016-2021)
Figure 74. Roche Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2016-2021)
Figure 75. Siemens Healthineers AG Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2016-2021)
Figure 76. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Infectious Disease In-vitro Diagnostic Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed